By Resolution of the Academic Board
A small innovation institution “Center of Molecular and Cell Bioengineering” will be established at Tyumen State University. The decision has been made by the University Academic Board.
The aim of the center is to develop biotechnological and bioengineering developments at the University, including development of test-systems to detect human and animal diseases, testing and production of a DNA vaccine (in cooperation with Boston University and SL Oncology LLC).
Key areas of operation of the institution will include development and manufacture of feed protein additives for production animals, development of genetically modified strains of microorganisms-producents of biologically active substances.
These projects shall be implemented at two levels: molecular-genetic and cellular.